Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alanine is a non-essential amino acid that exists in two primary forms: L-alanine and beta-alanine. L-alanine is a fundamental proteinogenic amino acid and a key participant in the glucose-alanine cycle, where it facilitates nitrogen transport from peripheral tissues to the liver and serves as a substrate for gluconeogenesis to maintain blood glucose levels. Beta-alanine is a non-proteinogenic amino acid that serves as the rate-limiting precursor for carnosine, a dipeptide that buffers hydrogen ions in skeletal muscle to delay fatigue during high-intensity exercise. Alanine is widely commercialized as a dietary supplement for metabolic support and athletic performance, and it is utilized as a food additive for flavor enhancement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alanine.